Fundraising Fox

Vizgen

Cambridge, US · Founded 2019 · Delaware corporation · 4 known investors

vizgen.com ↗

Vizgen develops spatial profiling instruments and reagents for high-throughput analysis of gene expression and protein distribution in tissue samples. The company serves research and diagnostic laboratories in the life sciences and precision oncology fields.

AI & Machine LearningBiotechDeep TechMedical Devicesin /vizgen@vizgen_inc

Founders & leadership

GE
George EmanuelScientific Cofounder, VP & Portfolio Owner, Instruments
JH
Jiang HeScientific Cofounder, VP & Portfolio Owner, Reagents & Scientific Affairs
RC
Robert CarsonExecutive Officer, Director
TL
Terry LoDirector
SB
Seth BensonExecutive Officer
SL
Simona LeviExecutive Officer
PG
Philip GardellaExecutive Officer
ME
Marijn E. DekkersDirector
AJ
Andrea JacksonDirector
KC
Keith CrandellDirector
CU
Christian UhrichDirector
MP
Matthew PosardDirector

Investors · 4

ARCH Venture Partners✓ verifiedChicago · $50K – $250M
M Ventures✓ verifiedLos Angeles · $10.8M
Northpond Ventures✓ verifiedBethesda · $100K – $5M
Novalis LifeSciencesreportedPortsmouthvia Marijn Dekkers · board

Reported raises · per SEC filings

Form D private placements
▶$47.8MraisedJan 2026 · 9 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Andrea JacksonDirector
  • Simona LeviExecutive Officer
  • Robert CarsonExecutive Officer, Director
  • Keith CrandellDirector
  • Matthew PosardDirector
  • Christian UhrichDirector
  • David WaltDirector
Offering amount
$50M
Amount sold
$47.8M
Proceeds to insiders
$931.4K
First sale
Dec 2025
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$3.5MraisedOct 2025 · 7 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Matthew PosardDirector
  • David WaltDirector
  • Andrea JacksonDirector
  • Keith CrandellDirector
  • Robert CarsonExecutive Officer, Director
  • Christian UrhichDirector
  • Simona LeviExecutive Officer
  • Chris GuiffreExecutive Officer
  • Terry LoDirector
Offering amount
$9.5M
Amount sold
$3.5M
First sale
Oct 2025
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$107.6MraisedOct 2024 · 61 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Robert CarsonExecutive Officer, Director
  • Andrea JacksonDirector
  • Keith CrandellDirector
  • Christian UhrichDirector
  • Matthew PosardDirector
  • Terry LoDirector
  • Seth BensonExecutive Officer
  • David WaltDirector
  • Simona LeviExecutive Officer
Amount sold
$107.6M
Proceeds to insiders
$400K
First sale
Oct 2024
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$85.2MraisedMay 2022 · 15 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Marijn E. DekkersDirector
  • Keith CrandellDirector
  • Matthew PosardDirector
  • Andrea JacksonDirector
  • David WaltDirector
  • Philip GardellaExecutive Officer
  • Terry LoExecutive Officer, Director
Offering amount
$105.2M
Amount sold
$85.2M
First sale
Apr 2022
Incorporated
Corporation, Delaware, 2019
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$37MraisedApr 2021 · 12 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Keith CrandellDirector
  • Andrea JacksonDirector
  • Philip GardellaExecutive Officer
  • Terry LoExecutive Officer, Director
  • Marijn E. DekkersDirector
  • David WaltDirector
Offering amount
$37M
Amount sold
$37M
First sale
Mar 2021
Incorporated
Corporation, Delaware, 2019
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$14MraisedOct 2019 · 3 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Dr. Peidong WangExecutive Officer, Director
  • Dr. Philip GardellaExecutive Officer
  • Dr. Jiang HeExecutive Officer
Offering amount
$14M
Amount sold
$14M
First sale
Oct 2019
Incorporated
Corporation, Delaware, 2019
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

In the news